Non-peptidic Thrombospondin-1 Mimics as Fibroblast Growth Factor-2 Inhibitors

New insights into the molecular interaction of the C-terminal sequence of CXCL4 with fibroblast growth factor-2

(2009) Laura Ragona et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Fibroblast Growth Factor-2 Antagonist and Antiangiogenic Activity of Long-Pentraxin 3-Derived Synthetic Peptides

(2009) D. Leali et al.   CURRENT PHARMACEUTICAL DESIGN

The FGF family: biology, pathophysiology and therapy

(2009) Andrew Beenken et al.   NATURE REVIEWS DRUG DISCOVERY

Thrombospondins: from structure to therapeutics

(2008) S. Kazerounian et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Thrombospondins: from structure to therapeutics

(2008) C. B. Carlson et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

The design, structures and therapeutic potential of protein epitope mimetics

(2008) John A. Robinson et al.   DRUG DISCOVERY TODAY

Differences between High- and Low-Affinity Complexes of Enzymes and Nonenzymes

(2008) Heather A. Carlson et al.   JOURNAL OF MEDICINAL CHEMISTRY

A Molecular Dynamics Study of the Interaction of d-Peptide Amyloid Inhibitors with Their Target Sequence Reveals a Potential Inhibitory Pharmacophore Conformation

(2008) Alexandra Esteras-Chopo et al.   JOURNAL OF MOLECULAR BIOLOGY

Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain

(2007) Barbara Margosio et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY